Universities Working With GSK On Research Project
Date posted:
News
GSK is collaborating with two universities in the Midlands on a research project exploring new treatments for chronic obstructive pulmonary disorder (COPD).
East Midlands Business Link revealed that the pharmaceutical giant will be working with life sciences researchers from the biomedical research centres (BRCs) at the universities of Leicester and Nottingham, who are exploring the use of genetics to aid the development of new therapies for COPD and related airway disorders.
The teams at the universities plan to combine laboratory experiments with large-scale computational analyses to try to better understand the disease progression, as well as why some patients with COPD experience more frequent flare ups.
Meanwhile, GSK will provide expertise in the area of drug discovery, with the hope that by working together they can speed up the development of innovative new treatments for COPD.
Director at the National Institute for Health Research Nottingham BRC professor Ian Hall commented: “Collaborations such as this, where each partner brings unique strengths to the research programme, are essential to drive forwards the drug discovery process.”
He added that this will help “identify the best individualised treatment options” for those suffering from COPD and related conditions.
This is just one life sciences project that is receiving investment in the Midlands at present, with a recent report by the D2N2 local enterprise partnership highlighting the need for continued investment in this specialism in the region.
The organisation has already provided £6.5 million in funding to support the construction of a new life sciences building near Nottingham.
If you need assistance with life science sales, contact us to tap into our expertise in this area.